Eugenia gracillima essential oil has pharmaceutical applications in pain and inflammation without toxic effects in mice

Ethnopharmacological relevance: Eugenia gracillima is widely used by the population in the manufacture of pulps and jellies, with popular reports of its use in the treatment of infections in the urinary system, respiratory and dermatological problems. A previous study reports that EO from E. gracillima leaves proved to be a promising antioxidant agent in combating the promastigote forms of protozoa. Despite this, this species has been little studied due to its pharmacological properties. Study objective: In this study, an essential oil extracted (EO) from Eugenia gracillima leaves was evaluated for its acute toxicity and anti-inflammatory, antinociceptive and behavioral effects in mice. Methods: The EO was obtained by hydrodistillation, and the composition analysis was performed by gas chro-matography coupled to mass spectrometry. Acute toxicity assessment was performed with observation of he-matological parameters and histopathological evaluation, as well as tests to investigate antinociceptive, anti-inflammatory activities and behavioral effects. Results: Chromatographic analysis showed D-germacrene (16.10%), gamma-muurolene-g (15.60%) and bicyclo-germacrene (8.53%) as the majority of compounds. In the toxicity evaluation, no death or physiological changes were observed in mice treated with a single oral dose of up to 5000 mg/kg, and it did not lyse erythrocytes in vitro. The hematological parameters evaluated were not changed after treatment; however, 5,000 mg/kg pro-moted an increase in transaminase levels. In the histopathological evaluation, only the animals that received the dose of 5000 mg/kg showed discrete leukocyte infiltration around the centrilobular vein in the liver. Anti-nociceptive activity was detected through tests of acetic acid-induced writhing, formalin, and tail flick, promoted in part by the opioid receptor pathway. In the evaluation of anti-inflammatory activity, a reduction in inflam-mation was observed in the paw edema test and a decrease in the migration of leukocytes and neutrophils in the peritonitis test. The open field and elevated plus maze tests showed that EO did not affect the animals' motor functions or exploratory activity. Conclusion: It was concluded that the essential oil of E. gracillima has potential for the development of phar-maceutical formulations with analgesic and anti-inflammatory actions in non-toxic concentrations.

Automated summary

In this study, the essential oil extracted from Eugenia gracillima leaves was evaluated for its acute toxicity and anti-inflammatory, antinociceptive, and behavioral effects in mice. The results showed that the essential oil has potential for the development of pharmaceutical formulations with analgesic and anti-inflammatory actions in non-toxic concentrations.